Acurx Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $2.5M |
| Jun 2020 | — | — | $2.0M |
| Sep 2020 | — | — | $3.4M |
| Dec 2020 | $522.4K | $3.2M | $3.2M |
| Mar 2021 | — | — | $2.6M |
| Jun 2021 | $1.9M | $17.4M | $17.1M |
| Sep 2021 | $712.4K | $15.0M | $14.5M |
| Dec 2021 | $843.9K | $13.3M | $13.0M |
| Mar 2022 | $633.0K | $11.3M | $11.1M |
| Jun 2022 | $473.9K | $9.3M | $9.1M |
| Sep 2022 | $1.2M | — | $10.6M |
| Dec 2022 | $2.1M | $9.4M | $9.1M |
| Mar 2023 | $2.1M | — | $7.2M |
| Jun 2023 | $3.0M | — | $9.1M |
| Sep 2023 | $3.2M | — | $7.1M |
| Dec 2023 | $3.0M | $7.7M | $7.5M |
| Mar 2024 | $3.1M | $9.1M | $8.9M |
| Jun 2024 | $3.2M | $6.6M | $6.4M |
| Sep 2024 | $3.3M | — | $5.8M |
| Dec 2024 | $3.2M | $3.9M | $3.7M |
| Mar 2025 | $2.5M | — | $4.6M |
| Jun 2025 | $2.6M | — | $6.1M |
| Sep 2025 | $2.5M | $6.1M | $5.9M |
| Dec 2025 | $2.4M | $7.7M | $7.6M |
| Mar 2026 | $2.5M | $9.5M | $9.3M |
| Jun 2026 | $2.8M | $11.0M | $10.7M |